John Tan

John Tan

Reed Smith

Contact  |  View Bio  |  RSS

Latest Posts › Compliance

Share:

China’s Life Sciences Regulatory Crackdown: September 10 Update

The regulatory enforcement environment in China remains tense, as both the Chinese government and media bring new actions and allegations against life sciences manufacturers in both the pharmaceutical and device sectors. We...more

9/11/2013 - Biotechnology China Compliance Enforcement Life Sciences Medicare Pharmaceutical

2012 FCPA Guidance: Key Points and Analysis

On November 14, 2012, the U.S. Department of Justice and the Securities and Exchange Commission released their long-awaited Foreign Corrupt Practices Act guidance in the form of a 120-page document entitled “A Resource Guide...more

11/26/2012 - Compliance DOJ FCPA FCPA Resource Guide SEC

2 Results
|
View per page
Page: of 1